ATE225183T1 - Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen - Google Patents

Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen

Info

Publication number
ATE225183T1
ATE225183T1 AT95941620T AT95941620T ATE225183T1 AT E225183 T1 ATE225183 T1 AT E225183T1 AT 95941620 T AT95941620 T AT 95941620T AT 95941620 T AT95941620 T AT 95941620T AT E225183 T1 ATE225183 T1 AT E225183T1
Authority
AT
Austria
Prior art keywords
growth factor
differentiation
pct
hepatocyte growth
hematopoietic cells
Prior art date
Application number
AT95941620T
Other languages
English (en)
Inventor
Paolo M Comoglio
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of ATE225183T1 publication Critical patent/ATE225183T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT95941620T 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen ATE225183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI942382A IT1271088B (it) 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
PCT/EP1995/004589 WO1996015802A1 (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells

Publications (1)

Publication Number Publication Date
ATE225183T1 true ATE225183T1 (de) 2002-10-15

Family

ID=11369904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941620T ATE225183T1 (de) 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen

Country Status (12)

Country Link
US (1) US5968501A (de)
EP (1) EP0793503B1 (de)
JP (1) JP3874024B2 (de)
AT (1) ATE225183T1 (de)
AU (1) AU707259B2 (de)
CA (1) CA2205914C (de)
DE (1) DE69528473T2 (de)
DK (1) DK0793503T3 (de)
ES (1) ES2183890T3 (de)
IT (1) IT1271088B (de)
PT (1) PT793503E (de)
WO (1) WO1996015802A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4865541B2 (ja) * 2003-04-08 2012-02-01 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド 化学誘引物質に対する増大させた感受性を有する幹細胞およびそれを産生および使用する方法
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
EP1702062A2 (de) * 2003-06-11 2006-09-20 Jan Remmereit Kern-umprogrammierung von zellen für die therapeutische verwendung
ES2293553T3 (es) * 2004-03-09 2008-03-16 Tohoku Technoarch Co., Ltd. Uso de factor de crecimiento de hepatocitos para promover la induccion de diferenciacion vascular.
JP4797186B2 (ja) * 2004-10-08 2011-10-19 剛史 汐田 末梢血中への造血幹細胞動員剤
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
JP6319304B2 (ja) * 2013-04-17 2018-05-09 日産化学工業株式会社 培地組成物及び当該培地組成物を用いた赤血球の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
EP0461560B1 (de) * 1990-06-11 1998-11-18 Toshikazu Nakamura Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
DE69131069T2 (de) * 1990-07-13 1999-07-15 Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
DE69230879T2 (de) * 1991-07-26 2000-08-03 Toray Industries, Inc. Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5599703A (en) * 1993-10-28 1997-02-04 The United States Of America As Represented By The Secretary Of The Navy In vitro amplification/expansion of CD34+ stem and progenitor cells

Also Published As

Publication number Publication date
PT793503E (pt) 2003-02-28
JPH10509951A (ja) 1998-09-29
ITMI942382A0 (it) 1994-11-24
CA2205914A1 (en) 1996-05-30
EP0793503A1 (de) 1997-09-10
AU4299696A (en) 1996-06-17
DE69528473T2 (de) 2003-07-10
AU707259B2 (en) 1999-07-08
EP0793503B1 (de) 2002-10-02
ITMI942382A1 (it) 1996-05-24
WO1996015802A1 (en) 1996-05-30
DE69528473D1 (de) 2002-11-07
IT1271088B (it) 1997-05-26
ES2183890T3 (es) 2003-04-01
JP3874024B2 (ja) 2007-01-31
US5968501A (en) 1999-10-19
DK0793503T3 (da) 2003-02-03
CA2205914C (en) 2009-04-07

Similar Documents

Publication Publication Date Title
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
ATE196648T1 (de) Verwendung von porösem calciumcarbonat als trägermaterial für in vitro zellkulturen.
ATE535250T1 (de) Zusammensetzungen enthaltend mitotisch inaktivierten allogenen fibroblasten und keratinozyten für verwendung in geweberegenerierung
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2000006704A3 (en) Hematopoietic cell composition for use in transplantation
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
TR200200897T2 (tr) Melez matrisler ve melez matriks karışımları
AU1116400A (en) A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
DE69430059D1 (de) Freisetzung und Mobilisierung hämatopoietischer Zellen
ATE145556T1 (de) Verwendung von interleukin-4 zur behandlung der festen tumoren
ATE514771T1 (de) Haartransplantation
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
ATE225183T1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
ATE437219T1 (de) Von monozyten stammende multipotente zelle momc
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
DE69526395D1 (de) Verwendung von Interferon-gamma zur Vermeidung der Proliferation und Differenzierung der primitiven Hämapoietischen Vorläuferzellen
SE8500470L (sv) Kompositioner for kosmetiskt, helso- och kroppsbevarande bruk
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
ATE124262T1 (de) Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
ATE191501T1 (de) Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen
DE69434968D1 (de) Tiermodell für hepatitis-virus infektion
PT765398E (pt) Populacao de celulas enriquecedoras em progenitores mieloides e linfoides e metodos de as fazer e utilizar
DE69837212D1 (de) Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0793503

Country of ref document: EP

EEIH Change in the person of patent owner